This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brasier, A. R. Articles by Habener, J. F. Search for Related Content PubMed PubMed Citation Articles by Brasier, A. R. Articles by Habener, J. F.

Synergistic Enhansons Located within an Acute Phase Responsive Enhancer Modulate Glucocorticoid Induction of Angiotensinogen Gene Transcription

Laboratory of Molecular Endocrinology, Massachusetts General Hospital and Howard Hughes Medical Institute, Harvard Medical School Boston, Massachusetts 02114

Address requests for reprints to: Dr. Allan R. Basier, Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Boston, Massachusetts 02114.

Abstract

The hepatic transcription of the angiotensinogen gene is regulated by both glucocorticoids and cytokines generated as products of the acute phase reaction. We have identified a multimodular enhancer in the 5'-flanking region of the rat angiotensinogen gene that mediates these responses and consists of an acute phase response element (APRE) flanked on both sides by adjacent glucocorticoid response element consensus motifs (GREs). Induction of transcription by the cytokine interleukin-1 (IL-1) is glucocorticoid dependent and mediated through the APRE. The APRE binds in a mutually exclusive manner a cytokine/phorbol ester-inducible protein (BPi), indistinguishable from nuclear factor kB, and a family of constitutive liver proteins (BPcs) related to the heat-stable transcription factor C/EBP. Using mutated 5'-flanking sequences of the angiotensinogen gene fused to a firefly luciferase reporter gene transfected into hepatoblastoma (HepG2) cells, we have mapped enhanson sequences required for the transcriptional response to glucocorticoids. Two functionally distinct GREs are identified by deletion and site-directed mutagenesis, both of which mediate glucocorticoid-stimulated transcription in vivo. Glucocorticoid-induced transcription mediated by the angiotensinogen gene enhancer is, furthermore, dependent on the occupancy of the APRE by either the BPi or a member of the BPc family because a mutant APRE that binds neither BPi nor BPc exhibits an attenuated glucocorticoid responsiveness. Mutant APREs that permit exclusive binding of either BPi or BPc synergistically transmit the glucocorticoid response mediated by one or the other of the adjacent GREs. Thus, the induction of angiotensinogen gene transcription involves interaction between the glucocorticoid receptor and either one of the APRE-binding proteins: either the cytokine-inducible NFkB or the constitutive family of C/EBP-like proteins, bound to adjacent enhansons in a mutually synergistic enhancer complex.

FOOTNOTES

This work was supported in part by NIH Grant DK-30834.

Received for publication July 12, 1990. Revision received September 7, 1990. Accepted for publication September 13, 1990.

This article has been cited by other articles:

				K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF]

				J. C. Webster, R. M. Huber, R. L. Hanson, P. M. Collier, T. F. Haws, J. K. Mills, T. C. Burn, and E. A. Allegretto Dexamethasone and Tumor Necrosis Factor-{alpha} Act Together to Induce the Cellular Inhibitor of Apoptosis-2 Gene and Prevent Apoptosis in a Variety of Cell Types Endocrinology, October 1, 2002; 143(10): 3866 - 3874. [Abstract] [Full Text] [PDF]

				I. Bossis and T. E. Porter Ontogeny of Corticosterone-Inducible Growth Hormone-Secreting Cells during Chick Embryonic Development Endocrinology, July 1, 2000; 141(7): 2683 - 2690. [Abstract] [Full Text] [PDF]

				L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF]

				L. E. Cornett, F. C. Hiller, S. E. Jacobi, W. Cao, and D. W. McGraw Identification of a Glucocorticoid Response Element in the Rat beta 2-Adrenergic Receptor Gene Mol. Pharmacol., December 1, 1998; 54(6): 1016 - 1023. [Abstract] [Full Text]

				D. K. Scott, P.-E. Stromstedt, J.-C. Wang, and D. K. Granner Further Characterization of the Glucocorticoid Response Unit in the Phosphoenolpyruvate Carboxykinase Gene. The Role of the Glucocorticoid Receptor-Binding Sites Mol. Endocrinol., April 1, 1998; 12(4): 482 - 491. [Abstract] [Full Text]

				A. R. Brasier, J. Li, and K. A. Wimbish Tumor Necrosis Factor Activates Angiotensinogen Gene Expression by the Rel A Transactivator Hypertension, April 1, 1996; 27(4): 1009 - 1017. [Abstract] [Full Text]

				A. R. Brasier and J. Li Mechanisms for Inducible Control of Angiotensinogen Gene Transcription Hypertension, March 1, 1996; 27(3): 465 - 475. [Abstract] [Full Text]

				J. Chen, M. Nikolova-Karakashian, A. H. Merrill , Jr., and E. T. Morgan Regulation of Cytochrome P450 2C11 (CYP2C11) Gene Expression by Interleukin-1, Sphingomyelin Hydrolysis, and Ceramides in Rat Hepatocytes J. Biol. Chem., October 20, 1995; 270(42): 25233 - 25238. [Abstract] [Full Text] [PDF]

				T. Yujiri, M. Ware, C. Widmann, R. Oyer, D. Russell, E. Chan, Y. Zaitsu, P. Clarke, K. Tyler, Y. Oka, et al. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation PNAS, June 20, 2000; 97(13): 7272 - 7277. [Abstract] [Full Text] [PDF]